CEO SUMMARY: For clinical laboratories and anatomic pathology groups willing to adapt to the evolving needs of the American healthcare system, there are many positive opportunities. That’s the view of a Wall Street investment bank that just published a report on the lab testing sector. The report on healthcare trends includes commentary about developments in cancer care, acceptance of personalized medicine, and the growing activity in direct-to-consumer lab testing.
Investment Bank Bullish On Clinical Labs, Pathology
Multiple trends in healthcare opening doors for laboratories to deliver value in new ways
- By Joseph Burns
- | From the Volume XXII No. 11 - August 3, 2015 Issue
- Tags: accountable care, aco, anatomic pathologist, Anatomic pathology, anatomic pathology lab, anatomic pathology labs, cap, clinical lab, clinical laboratories, Clinical Laboratory, clinical laboratory industry, clinical laboratory test, clinical laboratory testing, clinical labs, companion diagnostic, Companion diagnostics, consumer lab testing, diagnostic testing, ehi, Fee-for-service, genetic test, genetic testing, genetic testing companies, genomics, lab administrator, lab executive, lab industry, lab test, lab test prices, lab testing, lab tests, lab work, laboratories, laboratory industry, laboratory medicine, laboratory test, laboratory testing, medical lab, medical labs, Medicare, pathologists, Pathology group, pathology groups, pathology lab, pathology labs, personalized medicine, pharmacogenomics, the clinical laboratory, the laboratory
